EUVIMEDEUVIMED entdecken
VergleichsstudieMultizentrische StudieRandomisierte kontrollierte StudieOpen Access

Oxygen vs Air at Birth for Moderate- to Late-Preterm Infants

Stacey R Peart, Brett J Manley, Jeanie L Y Cheong, Ju Lee Oei, Anneke C Grobler, Cecilia L Moore, Renae L Allen, Maria G Alda, Georgina Bell, Kavita Bhola, Krystal Carman, Koert de Waal und 23 weitere

JAMA · 2026

DOI: 10.1001/jama.2026.14201 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift JAMA, 2026. Verfasst von Stacey R Peart und 34 weiteren Autor:innen. Beteiligte Einrichtung: Newborn Services and Newborn Research, The Royal Women's Hospital, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Infant, Premature, Oxygen, Oxygen Inhalation Therapy, Resuscitation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance The optimal initial fraction of inspired oxygen (F io 2 ) for delivery room resuscitation of neonates born at 32 to 35 weeks’ gestation is unknown.

Objective

To compare outcomes for neonates born at 32 to 35 weeks’ gestation when initiating resuscitation with F io 2 0.30 vs 0.21. Design, Setting, and Participants Unblinded, cluster randomized crossover trial in 26 Australian maternity hospitals, including tertiary, nontertiary, metropolitan, regional, public, and private sites, using a waiver of informed consent. All neonates born at participating sites at 32 to 35 weeks’ gestation without known major congenital anomalies who commenced respiratory support within 3 minutes of birth were enrolled from December 2022 to September 2025, with final follow-up in March 2026. Statistical analysis was conducted on October 29, 2025.

Intervention

Sites were randomly assigned to provide initial F io 2 of either 0.30 or 0.21 during the first 3 minutes of delivery room respiratory support. Sites crossed over to provide the alternative initial F io 2 halfway through their recruitment period. Main Outcomes and Measures The primary outcome was ongoing respiratory support when leaving the delivery room. Twelve secondary outcomes evaluated delivery room treatments and respiratory support until discharge.

Results

A total of 1818 eligible newborns (mean gestational age, 34.1 weeks; mean birth weight, 2165 g; 44.7% female) were included. Ongoing respiratory support when leaving the delivery room occurred in 700 of 964 newborns (72.6%) randomized to receive F io 2 0.30 and 626 of 854 newborns (73.3%) randomized to receive F io 2 0.21 (risk difference, −0.83 [95% CI, −4.33 to 2.67]). Of the 12 secondary outcomes, 10 were not significantly different between newborns randomized to receive F io 2 0.30 vs 0.21, while 2 were. Newborns randomized to receive F io 2 0.30 were less likely to receive higher levels of support in the delivery room, including noninvasive positive pressure ventilation (606 of 964 [62.9%] vs 560 of 854 [65.6%]), endotracheal or supraglottic airway ventilation (20 of 964 [2.1%] vs 24 of 854 [2.8%]), or cardiac compressions or epinephrine (19 of 964 [2.0%] vs 25 of 854 [2.9%]; proportional odds ratio, 0.70 [95% CI, 0.52-0.95]). Fewer newborns in the F io 2 0.30 group received endotracheal ventilation beyond the delivery room (61 of 959 [6.4%] vs 79 of 852 [9.3%]; risk ratio, 0.69 [95% CI, 0.47-0.91]). Conclusions and Relevance For neonates born at 32 to 35 weeks’ gestation, there was no difference between those commencing resuscitation with F io 2 0.30 vs F io 2 0.21 in the proportion still receiving respiratory support when leaving the delivery room. Trial Registration anzctr.org.au Identifier: ACTRN12621001267842

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Infant, PrematureOxygenOxygen Inhalation TherapyResuscitationRespiration, ArtificialFemaleHumansInfant, NewbornMaleAirCross-Over StudiesDelivery RoomsGestational AgeAustraliaHospitals, Maternity

Substanzen

Oxygen

Autor:innen und Institutionen

  • Newborn Services and Newborn Research, The Royal Women's Hospital, Melbourne, Victoria, Australia.
  • Department of Obstetrics, Gynaecology and Newborn Health, The University of Melbourne, Melbourne, Victoria, Australia.
  • Clinical Sciences, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.
  • Mercy Perinatal, Mercy Hospital for Women, Melbourne, Victoria, Australia.
  • Department of Paediatrics, The University of Melbourne, Melbourne, Victoria, Australia.
  • National Health and Medical Research Council Clinical Trials Centre, The University of Sydney, Sydney, New South Wales, Australia.

Zitieren

APA

Peart, S. R., Manley, B. J., Cheong, J. L. Y., Oei, J. L., Grobler, A. C., Moore, C. L., Allen, R. L., Alda, M. G., Bell, G., Bhola, K., Carman, K., de Waal, K., Dombagahawaththage, C. A. N., Fan, W. Q., Fang, A. Y. W., Goyadi, P. K., Houghton, K. A., Jain, K. F., John, J., …, & AIROPLANE Trial Investigators and the IMPACT Clinical Trials Network for Mothers’ and Babies’ Health (2026). Oxygen vs Air at Birth for Moderate- to Late-Preterm Infants. JAMA. https://doi.org/10.1001/jama.2026.14201

Vancouver

Peart SR, Manley BJ, Cheong JLY, Oei JL, Grobler AC, Moore CL, et al. Oxygen vs Air at Birth for Moderate- to Late-Preterm Infants. JAMA. 2026. doi:10.1001/jama.2026.14201

BibTeX
@article{Peart2026,
  author = {Peart, Stacey R and Manley, Brett J and Cheong, Jeanie L Y and Oei, Ju Lee and Grobler, Anneke C and Moore, Cecilia L and Allen, Renae L and Alda, Maria G and Bell, Georgina and Bhola, Kavita and Carman, Krystal and de Waal, Koert and Dombagahawaththage, C A Niroshan and Fan, Wei Qi and Fang, Alice Y W and Goyadi, Prasoon K and Houghton, Kerryn A and Jain, Kalpesh F and John, Jubal and Joshi, Datta and Kunjunju, Ansar and Marshall, Isaac R and Mills, John F and Nichol, Jane and Parkhurst, Katherine and Priyadarshi, Archana and Roberts, Calum T and Thomas, Niranjan and Tickell, David J and Walsh, Timothy and Yates, Kylie M and Ziffer, Joel and Davis, Peter G and Owen, Louise S and AIROPLANE Trial Investigators and the IMPACT Clinical Trials Network for Mothers’ and Babies’ Health, AIROPLANE Trial Investigators and the IMPACT Clinical Trials Network for Mothers’ and Babies’ Health},
  title = {Oxygen vs Air at Birth for Moderate- to Late-Preterm Infants},
  journal = {JAMA},
  year = {2026},
  doi = {10.1001/jama.2026.14201}
}
Kostenlos starten →